NGeneBio Co., Ltd.
Develops NGS-based molecular diagnostic products and software for oncology.
354200 | KO
Overview
Corporate Details
- ISIN(s):
- KR7354200008
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 구로구 디지털로 288 303호. 304호. 305호. 306호. 307호. 제지1층 제비 127호, 제지1층 제비 1, 구로구
Description
NGeneBio Co., Ltd. is a precision diagnostics company specializing in Next-Generation Sequencing (NGS) technology. The company develops and commercializes molecular diagnostic products, including in-vitro diagnostic (IVD) and companion diagnostic (CDx) solutions. Its primary focus is on oncology, offering NGS panels for the analysis of solid tumors and hematologic malignancies. Complementing its diagnostic assays, NGeneBio provides integrated bioinformatics software for comprehensive data analysis and interpretation. The company's portfolio also includes liquid biopsy technologies and personal genetic testing services, all aimed at providing precise genomic information to guide clinical decision-making.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.0 KB | ||
| 2024-12-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.9 KB | ||
| 2024-12-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.7 KB | ||
| 2024-12-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.8 KB | ||
| 2024-12-20 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 125.1 KB | ||
| 2024-12-17 00:00 |
증권발행결과(자율공시)
|
Korean | 7.9 KB | ||
| 2024-12-17 00:00 |
증권발행실적보고서
|
Korean | 87.1 KB | ||
| 2024-12-16 00:00 |
유상증자또는주식관련사채등의청약결과(자율공시)
|
Korean | 11.6 KB | ||
| 2024-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2024-12-11 00:00 |
유상증자또는주식관련사채등의청약결과(자율공시)
|
Korean | 8.9 KB | ||
| 2024-12-05 00:00 |
유상증자최종발행가액확정
|
Korean | 8.4 KB | ||
| 2024-12-05 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 34.4 KB | ||
| 2024-12-05 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 425.9 KB | ||
| 2024-12-05 00:00 |
[기재정정]투자설명서
|
Korean | 3.9 MB | ||
| 2024-12-02 00:00 |
[기재정정]투자설명서
|
Korean | 4.7 MB |
Automate Your Workflow. Get a real-time feed of all NGeneBio Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NGeneBio Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NGeneBio Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
